Pharmaceutical aerosol formulation
AssigneeAstraZeneca AB
InventorsGraham Buckton, Angela Columbano, Martin Grosvenor, Philip Wikeley
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical aerosol formulation comprising a surfactant that is an alkyl-polyglycoside of formula I, wherein DP is the average degree of polymerisation and has a value of from 1 to 4, and R is an alkyl chain or a mixture of alkyl chains having a chain length of from 6 to 22 carbon atoms; or a derivative thereof for the administration of a medicament for inhalation.
Claims10
A pharmaceutical aerosol formulation comprising a hydrofluoroalkane propellant, a medicament for inhalation and a surfactant, characterised in that the surfactant is an alkyl-polyglycoside of formula I:
- 2
- wherein DP is the average degree of polymerisation and has a value of from 1 to 4, and R is an alkyl chain or a mixture of alkyl chains having a chain length of from 6 to 22 carbon atoms;
- or a derivative thereof, characterised in that
- R is 2-ethyl-1-hexylglycoside and DP is 1.6;
- R is a mixture of C8 and C10 alkyl chains in a ratio of 60 C8:
- 40 C10 and DP is 1.5;
- R is a mixture of C16 and C8 alkyl chains and DP is 1.2-1.3;
- or
- R is a mixture of C20 and C22 alkyl chains and DP is 1.2-1.3, or the alkylpolyglycoside is
- n-dodecyl β-D-maltoside (C12G2), C10 DP 2.7, or C10-12 d.p. 1.4 and C12-14 d.p:
Dependencies are inferred from the claim text.